We are live on ! Find out more
AI

Advent International Portfolio holdings

AUM $4.24B
1-Year Est. Return 4.24%
This Fund
S&P 500
This Quarter Est. Return
+28.44%
1 Year Est. Return
+4.24%
3 Year Est. Return
+15.25%
5 Year Est. Return
-41.72%
10 Year Est. Return
+104.97%
AUM
$125M
AUM Growth
-$734M
Cap. Flow
-$1.89M
Cap. Flow %
-1.51%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$1.89M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 93.78%
2 Healthcare 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LULU icon
1
lululemon athletica
LULU
$13.2B
$117M 93.78%
20,105,279
– –
AEGR
2
DELISTED
Aegerion Pharmaceuticals
AEGR
$7.79M 6.22%
372,001
-75,000
-17% -$1.89M

Similar funds

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Advent International's Q4 2014 Portfolio in Review

As of Q4 2014, Advent International held 2 positions worth $125M, down 85% from $860M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. Advent International opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 94% of assets, down from 98% a quarter earlier, followed by Healthcare.

  • Advent International's biggest Q4 2014 reduction was Aegerion Pharmaceuticals, cutting an estimated $1.89M.
  • Advent International's ten largest holdings make up 100% of its $125M portfolio in Q4 2014.
  • Advent International opened 0 new positions and closed 0 in Q4 2014.
  • Advent International's portfolio value fell 85% quarter-over-quarter to $125M.

Based on Advent International's 13F filing for Q4 2014, filed 12 Feb 2015.